Drug Trial Registrations Must Have “Useful Information,” Journal Editors Say
This article was originally published in The Pink Sheet Daily
Executive Summary
International Committee of Medical Journal Editors says some manufacturers are using a “meaningless phrase” in place of a drug’s name for trial registries. Editors adopt WHO minimal registration data set of 20 items; registrations with missing fields or fields with “uninformative terminology” will be considered “inadequate.”